Strong Consumables Growth Drives Luminex's Q4 Revenues up 8 Percent
February 08, 2011
Strong Consumables Growth Drives Luminex's Q4 Revenues up 8 Percent
The firm reported consumables growth of 49 percent year over year, while systems sales jumped 11 percent. Luminex beat Wall Street estimates on both the top and bottom line.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Luminex Discloses GenturaDx Loss of $19.8M in 2011, $18.5M in H1 2012
September 18, 2012 / GenomeWeb Daily News - Luminex Posts 30 Percent Q1 Revenue Growth
May 7, 2010 / GenomeWeb Daily News - Luminex Leveraging Advanced Liquid Logic Alliance to Develop Field-based MDx/Immunoassay System
May 16, 2013 / PCR Insider - Despite Continued Genotyping Growth, Weak Expression Sales Force Affymetrix to Suspend Guidance
May 7, 2013 / BioArray News - Luminex in Alpha Stage for New MDx Platform; Ups R&D Spending to Prep for Market
May 2, 2013 / PCR Insider